Species specificity in the blood cholesterol-lowering effect of YM-16638

British Journal of Pharmacology

Volumn 118, Issue 1, 1996, Pages 174-178

  Goto, Shoichiro ^a   Shimokawa, Teruhiko ^a   Ugawa, Toru ^a   Hisamichi, Nami ^a   Masuyama, Youichi ^a   Iizumi, Yuichi ^a   Sato, Noboru ^a   Takenaka, Toichi ^a   Kodama, Tatsuhiki ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Alanine aminotransferase; Human subjects; Hypocholesterolaemic effect; Leukotriene antagonist; Old world monkeys; Species specificity; YM 16638

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; [5 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPYLTHIO] 1,3,4 THIADIAZOL 2 YLTHIO]ACETIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HAMSTER; HUMAN; HUMAN EXPERIMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MONKEY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; RAT; RHESUS MONKEY; SPECIES DIFFERENCE; SQUIRREL MONKEY; WEIGHT GAIN;

EID: 0029873940     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15382.x     Document Type: Article

References (17)

1. ALLAIN, C.C., POON, L.S. & CHAN, C.S.G. (1974). Enzymatic determination of total serum cholesterol. Clin. Chem., 20, 470-475.
2. BURNSTEIN, M., SCHOLINICH, H.R. & MORFIN, R. (1970). Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res., 11, 583-595.
3. DHAI, R. (1979). Decreased aminotransferase activity of serum and various tissues in the rat after cefazolin treatment. Clin. Chem., 25, 1263-1266.
4. EACHO, P.I., FOXWORTHY, P.S., JOHNSON, W.D & VAN LIER, R.B.L. (1985). Characterization of liver enlargement induced by compound LY171883 in rats. Fund. Appl. Toxicol., 5, 794-803.
5. ENDO, A. (1992). The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res., 33, 1569-1582.
6. ENDO, A., KURODA, M. & TANZAWA, K. (1976). Competitive inhibition of 3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett., 72, 323-326.
7. FEUER, G. (1977). Alanine aminotransferase activity of rat tissues following the administration of cefazolin. Toxicol. Appl. Pharmacol., 41, 185-186.
8. FEUER, G. (1981). Effect of cefazolin on aminotransferase activity in the rat. J. Toxicol. Environ. Health, 7, 593-606.
9. 4 antagonist. J. Pharmacol. Exp. Ther., 233, 148-157.
10. FOXWORTHY, P.S., PERRY, D.N., HOOVER, D.M. & EACHO, P.I. (1990). Changes in hepatic lipid metabolism associated with lipid accumulation and its reversal in rats given the peroxisome proliferator LY171883. Toxicol. Appl. Pharmacol., 106, 375-381.
11. GRUNDY, S.M. (1986). Cholesterol and coronary heart disease. J. Am. Med. Ass., 28, 2849-2858.
12. 4 antagonist, compound LY171883 on Fisher 344 rats and rhesus monkeys. Fund. Appl. Toxicol., 14, 123-130.
13. MARSHALL, W.S., GOODSON, T., CULLINAN, G.J., SWANSON-BEAN, D., HAISHI, K.D., RINKEMAN, L.E. & FLEISCH, J.H. (1987). Leukotriene receptor antagonists. I. Synthesis and structure activity relationships of alkoxyacetophenone derivatives. J. Med. Chem., 30, 682-689.
14. SIEDEL, J., SCHLUMBERGER, H., KLOSE, S., ZIEGENHORN, J. & WAHLENFELD, A.W. (1981). Improved reagent for the enzymatic determination of serum cholesterol. J. Clin. Chem. Clin. Biochem., 19, 838-841.
15. SPADY, D.K. & DIETSCHY, J.M. (1985). Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc. Natl. Acad. Sci. U.S.A., 82, 4526-4530.
16. TOMIOKA, K., GARRIDO, R., STEVENSON, J.S. & ABRAHAM, W.M. (1989). The effect of an orally active leukotriene (LT) antagonist YM-16638 on antigen-induced early and late airway responses in allergic sheep. Prostaglandins Leukotrienes Essential Fatty Acids, 36, 43-47.
17. TOMIOKA, K., YAMADA, T., MASE, T., HARA, H. & MURASE, K. (1988). Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4-thiadiazol-2-yl] thio] acetic acid. Arzneim.-Forsch. Drug Res., 38, 682-685.